Bellerophon Therapeutics Inc

NASDAQ:BLPH   11:10:31 AM EDT
0.92
-0.12 (-11.32%)
Earnings Announcements

Bellerophon Provides Clinical Program Update And Reports First Quarter 2022 Financial Results

Published: 05/11/2022 12:38 GMT
Bellerophon Therapeutics Inc (BLPH) - Bellerophon Provides Clinical Program Update and Reports First Quarter 2022 Financial Results.
Q1 Loss per Share $0.59.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.61

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.56

More details on our Analysts Page.